Long-term ADT Found to Raise Risk of Cardiovascular Death

Long-term ADT Found to Raise Risk of Cardiovascular Death

281972

Long-term ADT Found to Raise Risk of Cardiovascular Death

Long-term exposure to androgen deprivation therapy (ADT), a common treatment for prostate cancer, is associated with worse cardiorespiratory fitness and a higher risk of cardiovascular death, a new study reports. Men who received ADT therapy for more than six months were ultimately found to have a nearly four times higher risk of death than those not exposed to the therapy. The study, “Reduced Cardiorespiratory Fitness and Increased Cardiovascular Mortality After Prolonged Androgen Deprivation Therapy for…

You must be logged in to read/download the full post.